Tag: C. difficile

1. Bezlotoxumab therapy associated with significantly lower rate of recurrent C. difficile infection compared to placebo. 2. Actoxumab alone did not prevent ...

 1. In a randomized control trial, administration of multispecies probiotics did not affect the incidence of antibiotic-associated diarrhea as defined by ...

1. In a very large retrospective cohort of hospitalized pediatric patients, the incidence of C. difficile infection decreased from 7.09 ...

1. SER-109, an oral microbiome therapy, showed superiority over placebo in reducing the recurrence of C. difficile infection. 2. SER-109 ...

Effect of Oral Capsule – vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection The most efficacious means of reducing recurrent ...

1. Using frozen versus fresh fecal microbiota transplants for patients with recurrent or refractory Clostridium difficile infection resulted in similar rates of ...

1. Based on this prospective cohort study, only half of the patients who tested positive for the Clostridium difficile (C. ...

1. In this study, spores of non-toxigenic Clostridium difficile (C. difficile; M3 strain) administered for prevention of recurrent C. difficile ...

1. Patients on continuous proton pump inhibitor (PPI) had an increased risk of recurrence of their Clostridium difficile infection. 2. ...

1. The reduction of the gut bacterium, C. scindens, following antibiotic treatment was correlated with increased risk of C. diff ...